Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Aptamers for Treatment and Diagnosis of Autoantibody Based Dilated Cardiomyopathy

06.09.2012
<strong>Technology</strong><br>

Novel high affinity aptamers have been selected which inhibit the agonistic effect of autoantibodies specific for the second extracellular loop of human beta1-adrenergic receptors. Antibodies to the beta1-adrenergic receptor are detected in approximately 70% of idiopathic dilated cardiomyopathy patients and in nearly 100% of patients with Chagas’ cardiomyopathy and peripartum cardiomyopathy. The typical characteristics of these heart muscle disorders are ventricle enlargement and the inability to pump enough blood for the body's needs and finally severe heart failure. <br> The novel aptamers strongly inhibit the agonistic effect of beta1-adrenergic receptor-directed autoantibodies isolated from patients with idiopatic dilated cardiomyopathy, Chagas’ cardiomyopathy and peripartum cardiomyopathy, as demonstrated in a bioassay analyzing the beating frequency of rat cardiomyocytes. The specificity of the new aptamers to the autoantibodies relevant for the indicated cardiomyopathies has potential in the development of valuable new agents for diagnostic and therapeutic applications. </p> <b>Benefits:</b>

<ul> <li>Very effective treatment options for autoantibody-based cardiomyopathies - presumably with low side-effects.</li> <li>IC50 values of 100 nM or less in a rat cardiomyocyte beating assay </li> <li>Suitable as specific binders for pathogenic autoantibodies against beta1-adrenergic receptors in apheresis: An alternative to the costly and risky apheresis based on unspecific immunoadsorption</li> <li>Aptamer activity can be controlled by the application of antidotes </li> </ul> <p><strong>IP Rights</strong><br> European Patent Applic. (06/2010)<br> PCT Application (06/2011) </p> <p><strong>Origin</strong><br> • Charité – Universitätsmedizin Berlin<br> • Max-Delbrück –Centrum für Molekulare Medizin Berlin-Buch<br> • Aptares AG</p> <b>Find the technology offer and contact details here: <a href="http://www.ipal.de/technologieangebote/09014" target="_blank">http://www.ipal.de/technologieangebote/09014</a></b>

Weitere Informationen: PDF

ipal GmbH
Tel.: +49 (0)30/2125-4820

Ansprechpartner
Dr. Dirk Dantz

info@technologieallianz.de | TechnologieAllianz e.V.
Weitere Informationen:
http://www.technologieallianz.de/angebote.php?sort=sag&id=2639&lang=de
http://www.technologieallianz.de

Alle Nachrichten aus der Kategorie: Technologieangebote >>>

Die aktuellsten Pressemeldungen zum Suchbegriff Innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quanten-Cloud-Computing mit Selbstcheck

Mit einem Quanten-Coprozessor in der Cloud stoßen Innsbrucker Physiker die Tür zur Simulation von bisher kaum lösbaren Fragestellungen in der Chemie, Materialforschung oder Hochenergiephysik weit auf. Die Forschungsgruppen um Rainer Blatt und Peter Zoller berichten in der Fachzeitschrift Nature, wie sie Phänomene der Teilchenphysik auf 20 Quantenbits simuliert haben und wie der Quantensimulator das Ergebnis erstmals selbständig überprüft hat.

Aktuell beschäftigen sich viele Wissenschaftler mit der Frage, wie die „Quantenüberlegenheit“ auf heute schon verfügbarer Hardware genutzt werden kann.

Im Focus: Self-repairing batteries

UTokyo engineers develop a way to create high-capacity long-life batteries

Engineers at the University of Tokyo continually pioneer new ways to improve battery technology. Professor Atsuo Yamada and his team recently developed a...

Im Focus: Quantum Cloud Computing with Self-Check

With a quantum coprocessor in the cloud, physicists from Innsbruck, Austria, open the door to the simulation of previously unsolvable problems in chemistry, materials research or high-energy physics. The research groups led by Rainer Blatt and Peter Zoller report in the journal Nature how they simulated particle physics phenomena on 20 quantum bits and how the quantum simulator self-verified the result for the first time.

Many scientists are currently working on investigating how quantum advantage can be exploited on hardware already available today. Three years ago, physicists...

Im Focus: Accelerating quantum technologies with materials processing at the atomic scale

'Quantum technologies' utilise the unique phenomena of quantum superposition and entanglement to encode and process information, with potentially profound benefits to a wide range of information technologies from communications to sensing and computing.

However a major challenge in developing these technologies is that the quantum phenomena are very fragile, and only a handful of physical systems have been...

Im Focus: A step towards probabilistic computing

Working group led by physicist Professor Ulrich Nowak at the University of Konstanz, in collaboration with a team of physicists from Johannes Gutenberg University Mainz, demonstrates how skyrmions can be used for the computer concepts of the future

When it comes to performing a calculation destined to arrive at an exact result, humans are hopelessly inferior to the computer. In other areas, humans are...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

VideoLinks
Industrie & Wirtschaft
Veranstaltungen

MS Wissenschaft startet Deutschlandtour mit Fraunhofer-KI an Bord

17.05.2019 | Veranstaltungen

Wie sicher ist autonomes Fahren?

16.05.2019 | Veranstaltungen

Chemie – das gemeinsame Element

16.05.2019 | Veranstaltungen

VideoLinks
Wissenschaft & Forschung
Weitere VideoLinks im Überblick >>>
 
Aktuelle Beiträge

Integrierte Zuckermoleküle schonen Zellkulturen

17.05.2019 | Biowissenschaften Chemie

Erstmals Einsatz von gefäßschützendem Antikörper bei kardiogenem Schock

17.05.2019 | Biowissenschaften Chemie

Additive Maschinen lernen Superlegierungen kennen

17.05.2019 | Maschinenbau

Weitere B2B-VideoLinks
IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics